ADMA
Adma Biologics Inc. (ADMA)
NASDAQ · Healthcare
Adma Biologics Inc. annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Adma Biologics Inc. shareholder equity for the quarter ending December 31, 2025 were 477.3M, a 36.76% increase year-over-year.
- Adma Biologics Inc. shareholder equity for 2025 were 477.3M, a 36.76% increase from 2024.
- Adma Biologics Inc. shareholder equity for 2024 were 349.0M, a 158.14% increase from 2023.
- Adma Biologics Inc. shareholder equity for 2023 were 135.2M, a 11.03% decrease from 2022.
- Adma Biologics Inc. shareholder equity for 2022 were 152.0M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Adma Biologics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $477 |
| 2024 | $349 |
| 2023 | $135 |
| 2022 | $152 |
| 2021 | $141 |
| 2020 | $88 |
| 2019 | $26 |
| 2018 | $20 |
| 2017 | $40 |
| 2016 | $-4 |
| 2015 | $1 |
| 2014 | $6 |
| 2013 | $22 |
| 2012 | $9 |
| 2011 | $0 |
| Adma Biologics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $477 |
| 2024-12-31 | $349 |
| 2023-12-31 | $135 |
| 2022-12-31 | $152 |
| 2021-12-31 | $141 |
| 2020-12-31 | $88 |
| 2019-12-31 | $26 |
| 2018-12-31 | $20 |
| 2017-12-31 | $40 |
| 2016-12-31 | $-4 |
| 2015-12-31 | $1 |
| 2014-12-31 | $6 |
| 2013-12-31 | $22 |
| 2012-12-31 | $9 |
| 2011-12-31 | $0 |
Adma Biologics Inc. Shareholder Equity — FAQ
Adma Biologics Inc. (ADMA) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADMA's shareholder equity history?
The chart and table above show Adma Biologics Inc.'s shareholder equity by year and by quarter, including the growth rate.